v3.22.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenue    
Revenue $ 13,896 $ 7,294
Costs and expenses    
Selling, general and administrative 22,536 8,478
Research and development 146 28
Depreciation and amortization 7,391 2,764
Operating loss (27,132) (9,485)
Gain (loss) on derivatives 8,140 (14,008)
Income on equity method investment 257 196
Interest expense (1,255) (1,168)
Other income (expense), net 2 (144,091)
Loss before income taxes (19,988) (168,556)
Income tax (expense) benefit 0 0
Net loss (19,988) (168,556)
Other comprehensive income 0 1,389
Total comprehensive loss $ (19,988) $ (167,167)
Basic and diluted loss per share of common stock:    
Net loss per share of common stock, basic (in dollars per share) $ (0.17) $ (0.70)
Net loss per share of common stock, diluted (in dollars per share) $ (0.17) $ (0.70)
Weighted average number of shares outstanding - Basic (in shares) 115,479 242,289
Weighted average number of shares outstanding - Diluted (in shares) 115,479 242,289
Imagery & software analytical services    
Revenue    
Revenue $ 9,772 $ 5,998
Costs and expenses    
Costs excluding depreciation and amortization 5,907 4,379
Engineering & systems integration    
Revenue    
Revenue 4,124 1,296
Costs and expenses    
Costs excluding depreciation and amortization $ 5,048 $ 1,130

Source